tella, Inc. engages in the research and development of regenerative and cell medicines. It offers techniques and operational knowhow associated with dendritic cell vaccine therapy to affiliated medical institutions for the treatment of cancer. The company is also involved in the provision of consultation services on the establishment and maintenance of cell processing centers, and on introduction of management systems for cell cultivation; and lease of standard operating procedure and regular checks on manufacturing operation management and training of cell cultivation technicians. In addition, it offers consultation services on training of expertise regarding treatment practice; and support services for the assessment of therapies, documentation required for treatment practice, and cognition and information providing activities for physicians and patients. The company was founded in 2004 and is based in Tokyo, Japan.
tella inc (2191:Tokyo)
Phone: 81 3 5937 2111
Fax: 81 3 5937 2112www.tella.jp
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for 2191.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact TELLA INC, please visit www.tella.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.